Carlsmed, Inc.: COO Jeffrey Bertolini exercised options for 747 shares

What happened COO Jeffrey Bertolini exercised options for 747 shares at $5.92 per share (total $4,419) and sold 747 shares in an open-market transaction at $14.39 per share (total $10,749) on Oct 5, 2026. The filing also reports the disposition of the derivative instrument in connection with the exercise (747 shares at $0.00).

Key details

• Transaction date(s) and price(s): Oct 5, 2026 — exercise 747 shares @ $5.92 ($4,419); sale 747 shares @ $14.39 ($10,749); derivative disposition 747 @ $0.00 ($0).
• Shares owned after the transaction: not reported in the provided filing excerpt.
• Footnotes: the sale was effected pursuant to a Rule 10b5-1 trading plan adopted Mar 12, 2026 (F1). Vesting: 25% of the original option shares vested on Mar 3, 2026; the remaining 75% vests in 1/36th monthly installments thereafter subject to continued service (F2).
• Filing timeliness: Form 4 filed Oct 6, 2026 for transactions on Oct 5, 2026.

Why it may matter

• The filing shows an option exercise followed by the immediate sale of the resulting shares (cashless exercise).
• The reported sale was executed under a Rule 10b5-1 trading plan adopted Mar 12, 2026.
• The filing does not show why the insider traded or why the company acted.